Realcan Pharmaceutical Group Co., Ltd. logo

Realcan Pharmaceutical Group Co., Ltd. (002589)

Market Closed
11 Aug, 06:57
XSHE XSHE
¥
3. 23
-0.11
-3.2934%
¥
4.77B Market Cap
- P/E Ratio
0.02% Div Yield
248.28M Volume
- Eps
¥ 3.34
Previous Close
Add Transaction
Day Range
3.15 3.32
Year Range
2.38 4.69
Want to track 002589 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

002589 closed today lower at ¥3.23, a decrease of -3.2934% from yesterday's close, completing a monthly increase of 30.2419% or ¥0.75. Over the past 12 months, 002589 stock lost -0.6154%.
002589 pays dividends to its shareholders, with the most recent payment made on Jun 30, 2026. The next estimated payment will be in In 10 months on Jun 30, 2027 for a total of ¥0.002.
The last earnings report, released on Oct 31, 2024, exceeded the consensus estimates by 0.0052%. On average, the company has surpassed earnings expectations by 0.0055%, based on the last three reports.
Realcan Pharmaceutical Group Co., Ltd. has completed 3 stock splits, with the recent split occurring on May 15, 2017.
The company's stock is traded on one exchange.

002589 Chart

People also search for

Tecon Biology Co., Ltd.
¥ 7.18
-1.3736%
Shandong Yisheng Livestock Co., Ltd.
¥ 10.52
+5.3053%
Chongqing Baiya Sanitary Products Co., Ltd.
¥ 14.24
-2.2649%
CQ Pharmaceutical Holding Inc.
¥ 5.59
+1.4519%
Three Squirrels Inc.
¥ 17.85
-0.8333%

Realcan Pharmaceutical Group Co., Ltd. (002589) FAQ

What is the stock price today?

The current price is ¥3.23.

On which exchange is it traded?

Realcan Pharmaceutical Group Co., Ltd. is listed on XSHE.

What is its stock symbol?

The ticker symbol is 002589.

Does it pay dividends? What is the current yield?

Yes, It pays dividends and the current yield is 0.02%.

What is its market cap?

As of today, the market cap is 4.77B.

Has Realcan Pharmaceutical Group Co., Ltd. ever had a stock split?

Realcan Pharmaceutical Group Co., Ltd. had 3 splits and the recent split was on May 15, 2017.

Realcan Pharmaceutical Group Co., Ltd. Profile

Consumer Staples Distribution & Retail Industry
Consumer Staples Sector
Mr. Xu Han CEO
XSHE Exchange
CNE1000013X5 ISIN
CN Country
2,897 Employees
30 Jun 2026 Last Dividend
15 May 2017 Last Split
10 Jun 2011 IPO Date

Overview

Realcan Pharmaceutical Group Co., Ltd. is an expansive enterprise dedicated to the distribution and sale of medicines, medical devices, and medical consumables to medical institutions worldwide. Originally known as Realcan Pharmaceutical Co., Ltd., the company underwent a name change in December 2018 to better reflect its diverse operations across several healthcare sectors. Founded in 2004, Realcan Pharmaceutical Group has established a robust presence in the healthcare industry, with its headquarters located in Yantai, China. The company's broad reach and comprehensive offerings encompass several key areas, including Drug and Equipment Distribution, Medical Diagnosis, Academic Service, Digital Medical, Pharmaceutical Logistics, and Traditional Chinese Medicine, demonstrating a commitment to providing a full spectrum of healthcare products and services.

Products and Services

  • Drug and Equipment Distribution

    Realcan Pharmaceutical Group Co., Ltd. specializes in the sale of a wide range of drugs and medical devices, catering to the needs of healthcare providers and patients alike. This segment underlines the company's core business, focusing on the supply of essential pharmaceuticals and medical instruments across various disciplines.

  • Medical Diagnosis

    Supporting the healthcare industry’s diagnostic needs, the company provides cutting-edge tools and services. This includes the distribution of diagnostic equipment and technologies that enable medical professionals to accurately assess and diagnose patient conditions.

  • Academic Service

    Realcan emphasizes the importance of continuous learning and innovation in healthcare. Their academic services are designed to educate and update healthcare professionals on the latest medical research, techniques, and practices, ensuring superior patient care.

  • Digital Medical

    In response to the digital transformation in healthcare, Realcan offers digital medical solutions that integrate technology into healthcare processes. This includes health service platforms that improve the efficiency and accessibility of medical services for both providers and patients.

  • Pharmaceutical Logistics

    The company’s logistic segment ensures the timely and safe delivery of pharmaceuticals and medical supplies. Leveraging advanced logistics and supply chain solutions, Realcan provides both third-party logistics services and specialized pharmaceutical logistics to meet the complex demands of the healthcare industry.

  • Traditional Chinese Medicine

    Recognizing the value of traditional treatments, Realcan also deals in traditional Chinese medicine (TCM). This segment caters to the demand for holistic and alternative medical solutions, promoting the use and integration of TCM in modern healthcare.

  • Disinfection and Sterilization

    The company extends its healthcare offerings to include disinfection and sterilization services. These critical services ensure that medical institutions maintain a safe and sanitary environment, essential for preventing infections and ensuring patient safety.

Contact Information

Address: Building 13, Yantai, China, 264001
Phone: 86 53 5673 5656